Gather-ed - A Rash of Developments in Chronic Spontaneous Urticaria Treatment and Management

Target Professions:	DO, MD, Nurse Practitioner, Physician Assistant
Target Specialties:	Allergy and Immunology, Dermatology
Credits Available:	4.75 AMA PRA Category 1 Credits™

Chronic spontaneous urticaria (CSU) is a prevalent, potentially debilitating disease that can prove challenging to manage successfully. Although antihistamines, anti-IgE monoclonal antibodies, and off-label suppressants can alleviate recurrent hives and angioedema, many patients with CSU are refractory to treatments comprising the standard of care. These limitations have spurred the development and examination of novel agents, such as BTK inhibitors, in patients with inadequately controlled disease. Through this three-part, small-group educational program, allergists, dermatologists, and other ancillary clinicians can learn how to more effectively navigate the CSU differential diagnosis, select the most appropriate therapies, and address more challenging management scenarios tied to treatment de-escalation. In doing so, healthcare providers can ensure that the rash of therapeutic developments in CSU are used to their fullest potential.

CME/CE Accreditation Information

Itinerary

PART ONE

A Rash of Developments in Chronic Spontaneous Urticaria Treatment and Management - Baseline Assessment

Answer the following questions to assess your knowledge of the diagnosis and treatment of patients with chronic spontaneous urticaria.

Module 1 - Navigating the Challenging CSU Differential Diagnosis

This first module is designed to enhance your familiarity with the defining characteristics of CSU.

Module 2 - Examining Advancements in the Understanding of CSU Pathophysiology, Translating Knowledge to Therapy

This self-study module is designed to enhance your understanding of the pathophysiology mediating the development of CSU.

Module 3 - Optimizing the Long-Term Management of Patients with CSU

This module is designed to improve your ability to measure disease activity in CSU, define treatment success, de-escalate therapy in appropriate situations, and better coordinate care efforts with other members of the care team.

A Rash of Developments in Chronic Spontaneous Urticaria Treatment and Management - Final Assessment

Answer the following questions to assess your gained knowledge of the diagnosis and treatment of patients with chronic spontaneous urticaria.

Live Group Discussion 1

This live group discussion is centered around the educational content of the self-study modules that examined the differential diagnosis of CSU, emerging treatments, patient-reported outcomes, defining treatment success, treatment de-escalation, and strategies for multidisciplinary management.

PART TWO

Patient Case 1 – 28-year-old male with CSU who does not respond adequately to the standard of care

This activity features a 28-year-old male who presents to your clinic today with symptoms of uncontrolled CSU.

Patient Case 2 – 60-year-old female with CSU who does not respond adequately to the standard of care

This activity features a 60-year-old female who presents to your clinic today with symptoms of uncontrolled CSU.

Your Action Plan In Chronic Spontaneous Urticaria (CSU)

In light of the information reviewed and discussed during this program, please share an action plan that you will implement to improve the diagnosis and management for your patients with chronic spontaneous urticaria (CSU).

Live Group Discussion 2

This live group discussion is focused on the case studies found in the Group Challenges, which explore how to optimize the management of patients with CSU who are refractory to guideline-recommended antihistamines and anti-IgE therapies.

Interested in becoming a Group Leader?

Requirements:
Group leaders should be experts in the fields of allergy and immunology, dermatology, and chronic spontaneous urticaria. Apply Now